Use of antiresorptive drugs among older women: A case study in Wisconsin

American Journal of Health-System Pharmacy

Volumn 60, Issue 5, 2003, Pages 453-463

  Cline, Richard R ^a   Mott, David A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Calcium regulators; Data collection; Drug use; Estrogens; Geriatrics; Osteoporosis; Women

Indexed keywords

ANTIRESORPTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ETIDRONIC ACID; HORMONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; BREAST CANCER; COMMUNITY CARE; DEMOGRAPHY; ELDERLY CARE; ESTROGEN THERAPY; FEMALE; HEALTH INSURANCE; HEALTH STATUS; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; SELF MEDICATION; STATISTICAL MODEL; UNITED STATES; UTERUS CANCER; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG USE; INTRANASAL DRUG ADMINISTRATION; QUESTIONNAIRE; STATISTICAL ANALYSIS; UTILIZATION REVIEW;

ADMINISTRATION, INTRANASAL; AGED; AGED, 80 AND OVER; CALCITONIN; DATA INTERPRETATION, STATISTICAL; DIPHOSPHONATES; DRUG UTILIZATION REVIEW; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LOGISTIC MODELS; OSTEOPOROSIS; QUESTIONNAIRES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; WISCONSIN;

EID: 0038654188     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.5.453     Document Type: Article

References (35)

1. Fast facts on osteoporosis. www.osteo.org/docs/81.464737215.html (accessed 2002 Jan 24).
2. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285:785-95.
3. Dennison E, Cooper C. Epidemiology of osteoporotic fractures. Horm Res. 2000; 54(suppl 1):58-63.
4. Hobbs FB. The elderly population. www.census.gov/population/www/pop-profile/elderpop.html (accessed 2002 Jan 23).
5. Baron JA, Barrett J, Malenka D et al. Racial differences in fracture risk. Epidemiology. 1994; 5:42-7.
6. Siegel J. Aging into the 21st century (HHS-100-95-0017). www.aoa.dhhs.gov/aoa/stats/aging21/ (accessed 2002 Aug 21).
7. America's bone health: the state of osteoporosis and low bone mass in our nation. Washington, DC: National Osteoporosis Foundation; 2002.
8. Marottoli RA, Berkman LF, Cooney LM. Decline in physical function following hip fracture. J Am Geriatr Soc. 1992; 40:861-6.
9. Greendale GA, Barrett-Connor E, Ingles S et al. Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo study. J Am Geriatr Soc. 1995; 43:955-61.
10. Greenspan SL, Harris ST, Bone H et al. Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis. Am Fam Physician. 2000; 61: 2731-6.
11. Drug Topics: 2001 red book. Montvale, NJ: Medical Economics; 2001.
12. Grady D, Herrington D, Bittner V et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA. 2002; 288:49-57.
13. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002; 288:321-33.
14. Torgerson DJ, Bell-Syer SEM. Hormone replacement therapy and prevention of nonvertebral fractures. JAMA. 2001; 285:2891-7.
15. Pfeffer RI. Estrogen use in postmenopausal women. Am J Epidemiol. 1977; 105:21-9.
16. Cauley JA, Cummings SR, Black DM et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990; 163:1438-44.
17. Handa VL, Landerman R, Hanlon JT et al. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc. 1996; 44:1-6.
18. Newell DA, Markides KS, Ray LA et al. Postmenopausal hormone replacement therapy use by older Mexican - American women. J Am Geriatr Soc. 2001; 49:1046-51.
19. Andersen RM. Revisiting the behavioral model and access to care: does it matter? J Health Soc Behav. 1995; 36:1-10.
20. Aday LA, Awe WC. Health services utilization models. In: Gochman DS, ed. Handbook of health behavior research. I: Personal and social determinants. New York: Plenum Press; 1997.
21. Dillman DA. Mail and Internet surveys: the tailored design method. 2nd ed. New York: John Wiley; 2000.
22. Ganther JM, Wiederholt JB, Kreling DH. Measuring patients' medical care preferences: care seeking versus self-treating. Med Decis Making. 2000; 21:133-40.
23. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol. 1995; 85:6-10.
24. Stafford RS, Saglam D, Causino N et al. Low rates of hormone replacement therapy in visits to United States primary care physicians. Am J Obstet Gynecol. 1997; 177:381-7.
25. Area resource file overview. www.arfsys.com/overviewAccess.htm (accessed 2002 Mar 27).
26. Aday LA, Lee ES, Spears B et al. Health insurance and utilization of medical care for children with special health care needs. Med Care. 1993; 31:1013-26.
27. Long JS. Regression models for categorical and limited dependent variables. Thousand Oaks, CA: Sage; 1997.
28. Hosmer DW, Lemeshow S. Applied logistic regression analysis. 2nd ed. New York: John Wiley; 2000.
29. State of Wisconsin July 1, 1999, population estimates. www.dhfs.state.wi.us/population/99demog/wisconsin.htm (accessed 2002 Feb 12).
30. 1999 Family health survey. Madison, WI: Bureau of Health Information, Division of Health Care Financing, Wisconsin Department of Health and Family Services; 1999.
31. A profile of older Americans - 2001. Washington, DC: Administration on Aging; 2001.
32. Spraggins RE. Women in the United States: a profile. Washington, DC: U.S. Census Bureau; 2002; Census brief CENBR/00-01.
33. Medicare beneficiary survey data tables: the characteristics and perceptions of the Medicare population (1998) - section 2. www.hcfa.gov/surveys/mcbs (accessed 2002 Aug 23).
34. Frank R, Berndt ER, Donohue J et al. Trends in direct-to-consumer advertising of prescription drugs. Menlo Park, CA: Kaiser Family Foundation; 2002.
35. Soumerai SB, Ross-Degnan D. Inadequate prescription -drug coverage for Medicare enrollees - a call to action. N Engl J Med. 1999; 340:722-8.